united therapeutics glp-1 receptor agonist At the 2025 European Academy of Dermatology and Venereology (EADV) Congress, the results of a massive retrospective analysis on the risk of hair loss in patients taking agonists and GIP Frontiers | GLP-1 Receptor Agonists:

Celebrities and influencers such as Oprah Winfrey, Elon Musk and Rachael Knight Guellete are confirmed to be using GLP-1s and will often be seen promoting these products

A clear reading of FDA guidance says that a prescriber can authorize a custom formulation of semaglutide or tirzepatide, says Scott Brunner, the CEO of the Alliance for Pharmacy Compounding

We also thank the eQTLGen consortium, the FinnGen team, and other researchers and participants for providing publicly available data for this analysis

Durability and relapse: less rebound with surgery One key limitation of GLP-1 therapy is that its benefits often depend on ongoing use

When surgery is delayed or cancelled due to concerns about gastric emptying, hospitals incur financial loss through wasted operating time and resource reallocation